Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models

Jin Young Shin, Hyun Jung Park, Ha Na Kim, Se Hee Oh, Jae Sung Bae, Hee Jin Ha, Phil Hyu Lee

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Current evidence suggests a central role for autophagy in Alzheimer disease (AD), and dysfunction in the autophagic system may lead to amyloid-β (Aβ) accumulation. Using in vitro and in vivo AD models, the present study investigated whether mesenchymal stem cells (MSC s) could enhance autophagy and thus exert a neuroprotective effect through modulation of Aβ clearance In Aβ-treated neuronal cells, MSC s increased cellular viability and enhanced LC3-II expression compared with cells treated with Aβ only. Immunofluorescence revealed that MSC coculture in Aβ-treated neuronal cells increased the number of LC3-II -positive autophagosomes that were colocalized with a lysosomal marker. Ultrastructural analysis revealed that most autophagic vacuoles (AVs) in Aβ-treated cells were not fused with lysosomes, whereas a large portion of autophagosomes were conjoined with lysosomes in MSC s cocultured with Aβ-treated neuronal cells. Furthermore, MSC coculture markedly increased Aβ immunoreactivity colocalized within lysosomes and decreased intracellular Aβ levels compared with Aβ-treated cells. In Aβ-treated animals, MSC administration significantly increased autophagosome induction, final maturation of late AVs, and fusion with lysosomes. Moreover, MSC administration significantly reduced the level of Aβ in the hippocampus, which was elevated in Aβ-treated mice, concomitant with increased survival of hippocampal neurons. Finally, MSC coculture upregulated BEC N1/Beclin 1 expression in AD models. These results suggest that MSC s significantly enhance autolysosome formation and clearance of Aβ in AD models, which may lead to increased neuronal survival against Aβ toxicity. Modulation of the autophagy pathway to repair the damaged AD brain using MSC s would have a significant impact on future strategies for AD treatment.

Original languageEnglish
Pages (from-to)32-44
Number of pages13
JournalAutophagy
Volume10
Issue number1
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Autophagy
Mesenchymal Stromal Cells
Amyloid
Alzheimer Disease
Lysosomes
Coculture Techniques
Vacuoles
Neuroprotective Agents
Fluorescent Antibody Technique
Hippocampus
Cell Count
Neurons
Brain
Autophagosomes

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cell Biology

Cite this

Shin, Jin Young ; Park, Hyun Jung ; Kim, Ha Na ; Oh, Se Hee ; Bae, Jae Sung ; Ha, Hee Jin ; Lee, Phil Hyu. / Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models. In: Autophagy. 2014 ; Vol. 10, No. 1. pp. 32-44.
@article{a1fc8e82eb7c4e4aab8ceed781aff54d,
title = "Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models",
abstract = "Current evidence suggests a central role for autophagy in Alzheimer disease (AD), and dysfunction in the autophagic system may lead to amyloid-β (Aβ) accumulation. Using in vitro and in vivo AD models, the present study investigated whether mesenchymal stem cells (MSC s) could enhance autophagy and thus exert a neuroprotective effect through modulation of Aβ clearance In Aβ-treated neuronal cells, MSC s increased cellular viability and enhanced LC3-II expression compared with cells treated with Aβ only. Immunofluorescence revealed that MSC coculture in Aβ-treated neuronal cells increased the number of LC3-II -positive autophagosomes that were colocalized with a lysosomal marker. Ultrastructural analysis revealed that most autophagic vacuoles (AVs) in Aβ-treated cells were not fused with lysosomes, whereas a large portion of autophagosomes were conjoined with lysosomes in MSC s cocultured with Aβ-treated neuronal cells. Furthermore, MSC coculture markedly increased Aβ immunoreactivity colocalized within lysosomes and decreased intracellular Aβ levels compared with Aβ-treated cells. In Aβ-treated animals, MSC administration significantly increased autophagosome induction, final maturation of late AVs, and fusion with lysosomes. Moreover, MSC administration significantly reduced the level of Aβ in the hippocampus, which was elevated in Aβ-treated mice, concomitant with increased survival of hippocampal neurons. Finally, MSC coculture upregulated BEC N1/Beclin 1 expression in AD models. These results suggest that MSC s significantly enhance autolysosome formation and clearance of Aβ in AD models, which may lead to increased neuronal survival against Aβ toxicity. Modulation of the autophagy pathway to repair the damaged AD brain using MSC s would have a significant impact on future strategies for AD treatment.",
author = "Shin, {Jin Young} and Park, {Hyun Jung} and Kim, {Ha Na} and Oh, {Se Hee} and Bae, {Jae Sung} and Ha, {Hee Jin} and Lee, {Phil Hyu}",
year = "2014",
month = "1",
day = "1",
doi = "10.4161/auto.26508",
language = "English",
volume = "10",
pages = "32--44",
journal = "Autophagy",
issn = "1554-8627",
publisher = "Landes Bioscience",
number = "1",

}

Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models. / Shin, Jin Young; Park, Hyun Jung; Kim, Ha Na; Oh, Se Hee; Bae, Jae Sung; Ha, Hee Jin; Lee, Phil Hyu.

In: Autophagy, Vol. 10, No. 1, 01.01.2014, p. 32-44.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models

AU - Shin, Jin Young

AU - Park, Hyun Jung

AU - Kim, Ha Na

AU - Oh, Se Hee

AU - Bae, Jae Sung

AU - Ha, Hee Jin

AU - Lee, Phil Hyu

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Current evidence suggests a central role for autophagy in Alzheimer disease (AD), and dysfunction in the autophagic system may lead to amyloid-β (Aβ) accumulation. Using in vitro and in vivo AD models, the present study investigated whether mesenchymal stem cells (MSC s) could enhance autophagy and thus exert a neuroprotective effect through modulation of Aβ clearance In Aβ-treated neuronal cells, MSC s increased cellular viability and enhanced LC3-II expression compared with cells treated with Aβ only. Immunofluorescence revealed that MSC coculture in Aβ-treated neuronal cells increased the number of LC3-II -positive autophagosomes that were colocalized with a lysosomal marker. Ultrastructural analysis revealed that most autophagic vacuoles (AVs) in Aβ-treated cells were not fused with lysosomes, whereas a large portion of autophagosomes were conjoined with lysosomes in MSC s cocultured with Aβ-treated neuronal cells. Furthermore, MSC coculture markedly increased Aβ immunoreactivity colocalized within lysosomes and decreased intracellular Aβ levels compared with Aβ-treated cells. In Aβ-treated animals, MSC administration significantly increased autophagosome induction, final maturation of late AVs, and fusion with lysosomes. Moreover, MSC administration significantly reduced the level of Aβ in the hippocampus, which was elevated in Aβ-treated mice, concomitant with increased survival of hippocampal neurons. Finally, MSC coculture upregulated BEC N1/Beclin 1 expression in AD models. These results suggest that MSC s significantly enhance autolysosome formation and clearance of Aβ in AD models, which may lead to increased neuronal survival against Aβ toxicity. Modulation of the autophagy pathway to repair the damaged AD brain using MSC s would have a significant impact on future strategies for AD treatment.

AB - Current evidence suggests a central role for autophagy in Alzheimer disease (AD), and dysfunction in the autophagic system may lead to amyloid-β (Aβ) accumulation. Using in vitro and in vivo AD models, the present study investigated whether mesenchymal stem cells (MSC s) could enhance autophagy and thus exert a neuroprotective effect through modulation of Aβ clearance In Aβ-treated neuronal cells, MSC s increased cellular viability and enhanced LC3-II expression compared with cells treated with Aβ only. Immunofluorescence revealed that MSC coculture in Aβ-treated neuronal cells increased the number of LC3-II -positive autophagosomes that were colocalized with a lysosomal marker. Ultrastructural analysis revealed that most autophagic vacuoles (AVs) in Aβ-treated cells were not fused with lysosomes, whereas a large portion of autophagosomes were conjoined with lysosomes in MSC s cocultured with Aβ-treated neuronal cells. Furthermore, MSC coculture markedly increased Aβ immunoreactivity colocalized within lysosomes and decreased intracellular Aβ levels compared with Aβ-treated cells. In Aβ-treated animals, MSC administration significantly increased autophagosome induction, final maturation of late AVs, and fusion with lysosomes. Moreover, MSC administration significantly reduced the level of Aβ in the hippocampus, which was elevated in Aβ-treated mice, concomitant with increased survival of hippocampal neurons. Finally, MSC coculture upregulated BEC N1/Beclin 1 expression in AD models. These results suggest that MSC s significantly enhance autolysosome formation and clearance of Aβ in AD models, which may lead to increased neuronal survival against Aβ toxicity. Modulation of the autophagy pathway to repair the damaged AD brain using MSC s would have a significant impact on future strategies for AD treatment.

UR - http://www.scopus.com/inward/record.url?scp=84894468077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894468077&partnerID=8YFLogxK

U2 - 10.4161/auto.26508

DO - 10.4161/auto.26508

M3 - Article

C2 - 24149893

AN - SCOPUS:84894468077

VL - 10

SP - 32

EP - 44

JO - Autophagy

JF - Autophagy

SN - 1554-8627

IS - 1

ER -